Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
May 2014—WaferGen Bio-systems acquired the NGS library preparation business from IntegenX. Pursuant to the purchase agreement, the company acquired substantially all of the assets of IntegenX’s product line used in connection with developing, manufacturing, marketing, and selling instruments and reagents relating to library preparation for NGS.
May 2014—The Clinical and Laboratory Standards Institute released a new quality management systems standard: QMS15-A—Laboratory Internal Audit Program; Approved Guideline. The document provides guidance on how a laboratory can establish an internal audit program to enhance the quality of its services through continual improvement. CLSI, 610-688-0100
May 2014—Beckman Coulter Diagnostics and Hc1.com entered a strategic partnership wherein they will combine Beckman Coulter’s clinical diagnostic systems with Hc1.com’s software-as-a-service Healthcare Relationship Cloud.
May 2014—BioMérieux’s THxID-BRAF companion diagnostic test is now available through Hematogenix Laboratory Services.
May 2014—Dako released a paper titled “Immunohistochemistry in Prostate Pathology” that illustrates the significant impact immunohistochemistry can have on diagnostic prostate pathology.
May 2014—Illumina is making available new products that can be applied directly to the discovery and translation of genomic variation in blood and tissue associated with cancer.
May 2014—Biocare Medical released a mouse monoclonal SOX10 antibody. SOX10 is expressed in 97 to 100 percent of desmoplastic and spindle cell melanomas and in 100 percent of nevi.
May 2014—295-Eppendorf-03-14Eppendorf introduced a series of Eppendorf Serological Pipets for cell culture applications.
April 2014—EntroGen expanded its line of colorectal cancer screening products to include the EntroGen K-Ras and N-Ras Mutation Analysis kits. The kits are updated to include coverage for exon 2, 3, and 4 mutations in both genes. The company obtained a CE IVD mark for these products.
April 2014—Horizon Discovery signed a worldwide distribution agreement with Haplogen in which customers can access, directly from Horizon, Haplogen’s Haploid Gene Trap Mutant Collection of isogenic human cell lines deficient for the expression of single genes. This is the first time Horizon will distribute another company’s products.
